Cantourage UK has signed a partnership with LOT420, a cultivator of medical cannabis based in Montreal, Canada.
LOT420 is a licensed cannabis producer with a total area of approximately 2,000 m², a team of over 30 cannabis growers is dedicated to cultivating select cannabis strains.
Gabriel Newman, Co-Founder & CEO of Cantourage UK, commented: "In a dynamic market that continually calls for higher standards and patient-centric approaches, our partnership with LOT 420 signifies our commitment to patients who are seeking relief from their persistent ailments. Through collaboration with experienced cultivators like LOT 420, we strengthen our resolve to deliver accessible, top-tier medical cannabis products. The launch of LOT 420's product range in Germany has received a resounding reception from patients and we are delighted to announce that the first of many upcoming varieties are available to UK patients".
"With the help of our partners at Cantourage, LOT420 has been able to establish itself within the German medical market as one of the premium producers offering high-quality medicine," said Stefan Macdonald, CEO of LOT420. "We are excited to announce that as of today, via Cantourage, medical patients in the UK will be able to be prescribed LOT420's premium cannabis flowers for their treatment."
For more information:
Cantourage 
www.cantourage.com